Tectonic Therapeutic
TECX | NASDAQ
$20.98
-$0.16 (-0.76%)
At close: Nov 16, 2026, 4:00 PM ET
$20.98
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-0.76%
(1D)Rating
28.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #849/1021 (Top 83%)
Key Statistics
Market Data
Market Cap $410.15M
1D Range
20.53 21.42
52W Range
17.93 37.93
Valuation (TTM)
PE -4.53
PB 1.79
EV/EBITDA -2.03
Valuation (NTM)
Forward PE N/A
Forward PEG -0.24
Price Target $80.00
Cash Flow
FCF Yield -16.9%
SBC Adj. FCF Yield -20.9%
SBC Impact -23.8%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y 41.9% |
48.9%
FCF 3Y | 5Y -12.3% |
5.7%
Returns
ROA -36.1%
ROE -37.7%
ROIC -41.4%
Financial Health
Net Cash
$230.75M
Current Ratio 19.71
Interest Coverage -3,216.43
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm dedicated to the identification and progression of biologic therapies, primarily therapeutic proteins and antibodies, that re...
Sector Healthcare
Industry Biotechnology
Employees 60
IPO Date Jun 21, 2018
Website tectonictx.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
3
Consensus
Buy
Price Target
$80.00
Upside
+281.32%
Buy (3)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove TECX